Healthy cells can transfer mitochondria to unhealthy neighbors, offering a possible treatment for a group of rare genetic diseases, a Stanford Medicine-led study shows.

Paper co-led by UCLA Health outlines how biological tests could help match psychiatric patients to medications with less trial and error.

**Note this is an early release from the Annual Meeting of the European Association for the Study of Diabetes [EASD]. Please credit the meeting when using this research**

New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28th – Oct 2nd) shows, with the use of continuous glucose monitoring (CGM) devices people with type 1 diabetes can complete a marathon safely and achieve finishing times similar to runners without diabetes. The study is conducted by Michał Kulecki, Dr Andrzej Gawrecki, and colleagues at Poznan University of Medical Sciences and Raszeja City Hospital, Poznan, Poland.

They account for nearly 83% of all cells in the human body, yet red blood cells are often portrayed as little more than bags of hemoglobin ferrying oxygen from the lungs to the heart and beyond. But new research from the University of Colorado Anschutz reveals that they are vastly more complex with far reaching consequences for health, exercise and fitness.

A team of researchers led by Professor Haruhisa Inoue (Department of Clinical Application, CiRA, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base editing can correct a disease-causing genetic mutation and alleviate neurodegeneration in hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P), providing proof of concept for a precision gene therapy for inherited motor neuron diseases.

Wake Forest University School of Medicine researchers identified SIRPα as a protein that may help triple-negative breast cancer spread to the brain and evade immune defenses, offering a potential target for future treatments.